Avidity Biosciences (RNA) - Cash on Hand per Share

Corporate emblem and logo of Avidity Biosciences (RNA)

Avidity Biosciences (RNA) focuses on developing RNA-based therapeutics, where success depends on regulatory approvals and venture financing. The current cash per share reflects liquidity dynamics, with the parameter equal to 10.81. Business growth relies on partnerships with pharma behemoths to attract capital, although geopolitical risks and overseas patent disputes could limit the expansion of its drugs.

Avidity - RNA Cash per Share (period 07/04/2022 - 11/20/2026)

Analytical breakdowns for Avidity Biosciences

- market value and analyst target forecast:
- market capitalization indicators:
- cash position and cash flow details:
Comprehensive company analysis:Avidity Corp - RNA
Original product of Avidity Biosciences, Inc.

Avidity Biosciences (RNA) requires significant liquid reserves for its large-scale investments in the development of the AOC platform, as reflected in the actual cash per share. This indicator, defined as the ratio of cash holdings to the number of shares outstanding, allows for an assessment of the company's financial cushion for conducting clinical trials without the need for emergency capital raises, confirming the business's stability.

Analysis of competing companies

TEM (Tempus AI Inc) - Cash Calculated per Single Share|Cash per Share QGEN|IONS - Cash on Hand per Share|Cash Funds per Share Repligen RGEN|Cash per Share CRISPR Therapeutics Corp CRSP|GeneDx Corp - Cash per Share|Ultragenyx Pharma (RARE) - Cash per Single Share|beamtx.com (BEAM) - Cash Funds per Share|SRPT: Cash Calculated per Single Share|Cash per Single Share TWST|TXG - Cash Funds Volume per Share|Cash per Share NTLA|Cash Funds Calculated per Share Stoke Therapeutics|Cash Funds per Share BioLife Solutions BLFS|Wave Life Sciences (WVE) - Cash on Hand per Share|Maze Therapeutics, Inc. - Cash per Share|Cash Funds Calculated per Share Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Cash Funds per Share|TSHA: Cash Calculated per Single Share|Cash Funds per Share uniQure Pharma|MGTX - Cash Funds Volume per Share|Cash per Share RGNX|Cash Funds per Share SLDB (Solid Biosciences)|Ocugen Corp - Cash per Single Share|PACB: Cash Funds per Single Share|benitec.com - Cash per Share|DSGN - Cash per Share|RCKT: Cash per Share|FDMT (4D Molecular Therapeutics Inc) - Cash Funds per Share|Cash per Single Share LXEO|Cash Funds per Share KRRO|Cash per Share EDIT|SLN - Cash on Hand per Share|Cash per Share PRQR (ProQR)|CDXS - Cash per Single Share|Sangamo Therapeutics Inc. - Cash per Share|NAUT - Cash per Share|MGX: Cash per Share|Cash per Single Share Precision BioSciences, Inc.|GBIO (Generation Bio) - Cash per Share|Boundless Bio Inc. (BOLD) - Cash Funds Calculated per Share|Cash per Single Share XCUR (exicuretx.com)|Imunon Inc - Cash Funds per Single Share|Cash per Share PHIO (Phio Pharmaceuticals Corp)|Amount of Cash per Share MBIO|RNAZ - Cash Funds per Share|Amount of Cash per Share BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Cash Funds per Share|Bluebird Bio - Amount of Cash per Share|IPA (ImmunoPrecise Antibodies Ltd) - Cash per Share|Cash on Hand per Share Omega Therapeutics, Inc. OMGA|Cash per Share OMIC|RGLS (Regulus Therapeutics Inc.) - Amount of Cash per Share|Cash per Share SYRS (Syros Pharmaceuticals Inc.)|Cash Calculated per Single Share TBIO (Codex DNA)|TCON - Cash Funds per Share|Cash on Hand per Share Unity Biotechnology